When Provista reverse merges into RXPC, its not like everyone will just be holding their collective breath till the upcoming Onko Sure patent is approved. The new company will have many other catalysts at their disposal in the meantime.
And they can still use Onko-Sure and LC Sentinel for LUNG CANCER ONLY while we are waiting for the patent approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.